579 related articles for article (PubMed ID: 20939698)
1. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
[TBL] [Abstract][Full Text] [Related]
2. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
4. Is early venous thromboembolism prophylaxis safe in trauma patients with intracranial hemorrhage.
Koehler DM; Shipman J; Davidson MA; Guillamondegui O
J Trauma; 2011 Feb; 70(2):324-9. PubMed ID: 21307729
[TBL] [Abstract][Full Text] [Related]
5. Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT.
Saadeh Y; Gohil K; Bill C; Smith C; Morrison C; Mosher B; Schneider P; Stevens P; Kepros JP
J Trauma Acute Care Surg; 2012 Aug; 73(2):426-30. PubMed ID: 22846950
[TBL] [Abstract][Full Text] [Related]
6. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
7. Does traumatic brain injury increase the risk for venous thromboembolism in polytrauma patients?
Valle EJ; Van Haren RM; Allen CJ; Jouria JM; Bullock MR; Schulman CI; Namias N; Livingstone AS; Proctor KG
J Trauma Acute Care Surg; 2014 Aug; 77(2):243-50. PubMed ID: 25058249
[TBL] [Abstract][Full Text] [Related]
8. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic prophylaxis in blunt traumatic intracranial hemorrhage: a retrospective review.
Depew AJ; Hu CK; Nguyen AC; Driessen N
Am Surg; 2008 Oct; 74(10):906-11. PubMed ID: 18942611
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
[TBL] [Abstract][Full Text] [Related]
12. Interrupted pharmocologic thromboprophylaxis increases venous thromboembolism in traumatic brain injury.
Salottolo K; Offner P; Levy AS; Mains CW; Slone DS; Bar-Or D
J Trauma; 2011 Jan; 70(1):19-24; discussion 25-6. PubMed ID: 21217476
[TBL] [Abstract][Full Text] [Related]
13. Late venous thromboembolism prophylaxis after craniotomy in acute traumatic brain injury.
Daley MJ; Ali S; Brown CV
Am Surg; 2015 Feb; 81(2):207-11. PubMed ID: 25642886
[TBL] [Abstract][Full Text] [Related]
14. Risks for hemorrhagic complications after placement of external ventricular drains with early chemical prophylaxis against venous thromboembolisms.
Tanweer O; Boah A; Huang PP
J Neurosurg; 2013 Nov; 119(5):1309-13. PubMed ID: 23991846
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury.
Scudday T; Brasel K; Webb T; Codner P; Somberg L; Weigelt J; Herrmann D; Peppard W
J Am Coll Surg; 2011 Jul; 213(1):148-53; discussion 153-4. PubMed ID: 21459632
[TBL] [Abstract][Full Text] [Related]
16. Meta-regression analysis to indirectly compare prophylaxis with dalteparin or enoxaparin in patients at high risk for venous thromboembolic events.
Dranitsaris G; Jelincic V; Choe Y
Clin Appl Thromb Hemost; 2012 Jun; 18(3):233-42. PubMed ID: 22387576
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.
Lin H; Faraklas I; Saffle J; Cochran A
J Trauma; 2011 Dec; 71(6):1557-61. PubMed ID: 22027887
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prophylaxis in neurosurgical trauma patients.
Tracy BM; Dunne JR; O'Neal CM; Clayton E
J Surg Res; 2016 Sep; 205(1):221-7. PubMed ID: 27621023
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score >2.
Minshall CT; Eriksson EA; Leon SM; Doben AR; McKinzie BP; Fakhry SM
J Trauma; 2011 Aug; 71(2):396-9; discussion 399-400. PubMed ID: 21825943
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of dalteparin and enoxaparin in a hospital setting.
Carson W; Schilling B; Simons WR; Parks C; Choe Y; Faria C; Powers A
J Pharm Pract; 2012 Apr; 25(2):180-9. PubMed ID: 21987527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
